PULMONER TROMBOEMBOLİ İLE KOMPLİKE AKCİĞER KANSERİ OLGUSU
Malign hastalık ile tromboz arasındaki ilişki yıllardır bilinmektedir. Ancak kansere bağlı klinik olarak önemli trombotik komplikasyonun gerçek insidansı hala bilinmemektedir. Daha önce KHAK tanısı alarak 2 kür KT alan 59 yaşında erkek olgu sağ yan ağrısı ve halsizlik yakınmaları ile 3. kür açısından değerlendirilmek üzere başvurdu. Toraks BT'de; santral yerleşimli kitlenin küçüldüğü ancak sağ hemitoraksta plevral efüzyonla birlikte sağ ana pulmoner arterde trombus izlendi. Olgu pulmoner emboli ile komplike KHAK olarak değerlendirildi. Olguyu; pulmoner embolinin gelişebileceği düşünülmediği takdirde yanlış değerlendirmelere neden olabileceği ve tedavi kararını değiştirebileceğini göstermesi açısından sunmayı uygun gördük.
A CASE OF LUNG CANCER COMPLICATED WITH PULMONARY THROMBOEMBOLI
The association between malignancy and clinical thrombosis has been recognised for several years. However true incidence of clinically significant thrombotic complications due to cancer stil unknown. 59 years old male admitted to hospital with the complaints of pain on the right side and fatigue who had the diagnosis of small cell lung cancer and got 2 cyclus of chemotherapy applied for the 3rd cyclus. Computed tomography performed. Thrombus observed in the right pulmonary artery. We evaluated the case as small cell lung cancer complicated with pulmonary embolus. We presented the case, because occurence of pulmonary embolism made us to evaluate the disease as progressive erroneously according to chest radiography at first.
___
- 1. Sutherland DE, Weitz IC, Liebman HA.
Thromboembolic complications of cancer:
epidemiology, pathogenesis, diagnosis, and
treatment. Am J Hematol 2003; 72: 43-52.
- 2. Thompson CM, Rodgers RL. Analysis of
autopsy records of 157 cases of carcinoma of
the pancreas with particular reference to the
incidence of thrombosis. Am J Med Sci 1952;
223: 469-76.
- 3. Sack GH, Levin J, Bell W. Trousseau’s syndrome
and other manifestations of chronic
disseminated coagulapathy in patients with
neoplasm: clinical, pathophysiologic and
therapeutic features. Medicine 1977; 56: 1-37.
- 4. Rickles FR, Levine MN, Dvorak HB. Abnormalities
of hemostasis in malignancy. In: Colman
RW, Hirsh J, Marder VJ, Clowes A, George JN,
editors. Hemostasis and thrombosis. Philadelphia:
Lippincott, Williams and Wilkins;
2001: 1132-52.
- 5. Rickles FR, Levine MN. Epidemiology of thrombosis
in cancer. Acta Haematol 2001;106: 6-12.
- 6. Lieberman JS, Borrero J, Urdoncta E, Wright
IS. Thrombophlebitis and cancer. J Am Med
Assoc 1961; 177: 542-5.
- 7. Vertun-Baranowska B, Fijalkowska A, Tomkowski
W, Filipecki S, Szymanska D. Pulmonary
embolism in malignancy of the lung: a retrospective
clinical evaluation and pathomorphologic
personal material. Pneumonol Alergol
Pol 1996; 64: 392-402.
- 8. Remiszewski P, Slodkowska J, Wiatr E,
Szopinski J, Radomski P, Plodziszewska M,
Rowinska-Zakrzewska E. Pulmonary thromboembolism
as the main or secondary cause of
death in patients treated for small cell lung
cancer. Pneumonol Alergol Pol 1999; 67:
470-6.